BETi dose-dependently reduced AKT phosphorylation and p21 phosphorylation at Thr145 in PTEN-deficient CRC cells, while the total level of p21 was increased by BETi (Fig. 6A, B). This evidence concerns the gene AKT1 and colorectal carcinoma.